» Articles » PMID: 33122821

Associations of Central and Peripheral Blood Pressure with the Renin-angiotensin-aldosterone System in Healthy Young Adults: the African-PREDICT Study

Overview
Journal Hypertens Res
Date 2020 Oct 30
PMID 33122821
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

This study investigated associations of brachial and central blood pressure (BP) with detailed renin-angiotensin-aldosterone system (RAAS) components in a healthy young population stratified according to ethnicity and sex. We included healthy black men (n = 285) and women (n = 304) and white men (n = 278) and women (n = 305) aged 20-30 years old. We derived central systolic BP (cSBP), measured clinic and 24-h systolic and diastolic BP. Aldosterone and equilibrium angiotensin levels were assessed and used for calculating angiotensin-derived markers for plasma renin activity (PRA-S, Angiotensin I + Angiotensin II), angiotensin-converting enzyme (ACE-S, Angiotensin II/Angiotensin I), and two markers for adrenal effects of angiotensin II, the aldosterone-to-renin ratio (ARR-S, Aldosterone/PRA-S) and the aldosterone-to-angiotensin II-ratio (AA2-R, Aldosterone/Angiotensin II) Young black men and women presented with lower RAAS components and higher cSBP compared to their white counterparts (all p ≤ 0.001). In multivariable-adjusted regression analyses, positive associations of cSBP with ARR-S and AA2-R and negative associations with PRA-S and angiotensin II were found for black women (all p ≤ 0.001); this pattern was also observed for 24-h and clinic BP (p ≤ 0.045). A similar trend of RAAS associations was present in black men but only for clinic BP (all p ≤ 0.047). In white men, negative associations between clinic SBP and PRA-S, angiotensin II and aldosterone were detected (all p ≤ 0.048). No associations were observed in white women. Positive associations of central and peripheral BP with the ratio of aldosterone to PRA-S and angiotensin II only in healthy, young black adults suggest that relative aldosterone excess may contribute to early hypertension development in this group.

Citing Articles

Hypertension in sub-Saharan Africa: the current profile, recent advances, gaps, and priorities.

Gafane-Matemane L, Craig A, Kruger R, Alaofin O, Ware L, Jones E J Hum Hypertens. 2024; 39(2):95-110.

PMID: 38698111 PMC: 11867975. DOI: 10.1038/s41371-024-00913-6.


Activation of the Renin-Angiotensin-Aldosterone System Is Attenuated in Hypertensive Compared with Normotensive Pregnancy.

Shoemaker R, Poglitsch M, Huang H, Vignes K, Srinivasan A, Cockerham C Int J Mol Sci. 2023; 24(16).

PMID: 37628909 PMC: 10454898. DOI: 10.3390/ijms241612728.


Soluble (Pro)renin Receptor Is Adversely Associated with Indices of Left Ventricular Structure and Function: The African-PREDICT Study.

Gafane-Matemane L, Kruger R, van Rooyen J, Gona P, Schutte A J Cardiovasc Dev Dis. 2022; 9(5).

PMID: 35621841 PMC: 9144018. DOI: 10.3390/jcdd9050130.

References
1.
Rayner B, Myers J, Opie L, Trinder Y, Davidson J . Screening for primary aldosteronism--normal ranges for aldosterone and renin in three South African population groups. S Afr Med J. 2001; 91(7):594-9. View

2.
Spence J, Rayner B . Hypertension in Blacks: Individualized Therapy Based on Renin/Aldosterone Phenotyping. Hypertension. 2018; 72(2):263-269. DOI: 10.1161/HYPERTENSIONAHA.118.11064. View

3.
Gafane L, Schutte R, van Rooyen J, Schutte A . Plasma renin and cardiovascular responses to the cold pressor test differ in black and white populations: The SABPA study. J Hum Hypertens. 2015; 30(5):346-51. DOI: 10.1038/jhh.2015.88. View

4.
Rayner B, Owen E, King J, Soule S, Vreede H, Opie L . A new mutation, R563Q, of the beta subunit of the epithelial sodium channel associated with low-renin, low-aldosterone hypertension. J Hypertens. 2003; 21(5):921-6. DOI: 10.1097/00004872-200305000-00016. View

5.
Gafane-Matemane L, van Rooyen J, Schutte R, Schutte A . Aldosterone and renin in relation to surrogate measures of sympathetic activity: the SABPA study. Cardiovasc J Afr. 2019; 30(1):34-40. DOI: 10.5830/CVJA-2018-065. View